Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Eledoisin is a specific agonist of NK2 and NK3 receptors.Eledoisin is an undecapeptide of mollusk origin, belonging to the tachykinin family of neuropeptides.
Description | Eledoisin is a specific agonist of NK2 and NK3 receptors.Eledoisin is an undecapeptide of mollusk origin, belonging to the tachykinin family of neuropeptides. |
In vitro | Eledoisin increases the value recorded under basal conditions by 24.5±3.7%; while this stimulation is significantly (P<0.01) lowered to 13.1±1.9% by the simultaneous presence of CP99994. The same protocol is also used to characterize the sensitivity of Eledoisin stimulation to 0.1 μM SR48968 or 0.1 μM SB222200. SR48968 significantly (P < 0.01) lower the stimulation by Eledoisin, while SB222200 has no effect. Eledoisin stimulation is reduced by CP99994 and SR48968, NK1 and NK2 antagonists, respectively[1]. |
In vivo | Injection of Eledoisin (0.1-1 nmol/kg) into rats produces a biphasic cardiovascular response that consists of an initial fall of systemic blood pressure (8-15 mm Hg) followed by a rise (20-22 mm Hg). |
Synonyms | Eledone peptide |
Molecular Weight | 1188.4 |
Formula | C54H85N13O15S |
CAS No. | 69-25-0 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
H2O: 18.15 mg/mL (15.27 mM), Need ultrasonic and warming
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eledoisin 69-25-0 GPCR/G Protein Neuroscience Neurokinin receptor inhibit Inhibitor Eledone peptide inhibitor